AIT AUSTRIAN INSTITUTE OF TECHNOLOGY Clause Samples

AIT AUSTRIAN INSTITUTE OF TECHNOLOGY. GMBH (AIT, Project Coordinator, AT) Partner 2: UNIVERSITY OF GENEVA (UniGe, CH) Partner 3: UNIVERSITY OF CYPRUS (UCY, CY) Partner 4 ORBIS MEDISCH EN ZORGCONCERN (ORBIS, NL) Partner 5 FRAUNHOFER IGD (Fh-IGD, DE) Partner 6 Noldus Information Technology BV (Noldus, NL) Partner 7 CITARD SERVICES LTD (Citard, CY) Partner 8 ZOOBE MESSAGE ENTERTAINMENT GMBH (Zoobe, DE) Partner 9 MAISON DE RETRAITE DU PETIT-SACONNEX (MRPS, CH)
View SourceView Similar (12)
AIT AUSTRIAN INSTITUTE OF TECHNOLOGY. GMBH (AIT), established in ▇▇▇▇▇▇▇▇▇▇▇▇ ▇, ▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇▇, VAT number: ATU14703506,
View Source
AIT AUSTRIAN INSTITUTE OF TECHNOLOGY. GMBH (AIT, Project Coordinator, AT) Partner 2: UNIVERSITY OF GENEVA (UniGe, CH) Partner 3: UNIVERSITY OF CYPRUS (UCY, CY) Partner 4 ORBIS MEDISCH EN ZORGCONCERN (ORBIS, NL) Partner 5 FRAUNHOFER IGD (Fh-IGD, DE) Partner 6 Noldus Information Technology BV (Noldus, NL) Partner 7 CITARD SERVICES LTD (Citard, CY) Partner 8 ZOOBE MESSAGE ENTERTAINMENT GMBH (Zoobe, DE) Partner 9 MAISON DE RETRAITE DU PETIT-SACONNEX (MRPS, CH) 6.1 Introduction to this chapter 16 6.2 Miraculous-Life server setup 16 6.2.1 Operating System 16 2.2 Remote Desktop Connection 16
View Source
AIT AUSTRIAN INSTITUTE OF TECHNOLOGY. GMBH (AIT, Project Coordinator, AT) Partner 2: UNIVERSITY OF GENEVA (UniGe, CH) Partner 3: UNIVERSITY OF CYPRUS (UCY, CY) Partner 4 ORBIS MEDISCH EN ZORGCONCERN (ORBIS, NL) Partner 5 FRAUNHOFER IGD (Fh-IGD, DE) Partner 6 Noldus Information Technology BV (Noldus, NL) Partner 7 CITARD SERVICES LTD (Citard, CY) Partner 8 ZOOBE MESSAGE ENTERTAINMENT GMBH (Zoobe, DE) Partner 9 MAISON DE RETRAITE DU PETIT-SACONNEX (MRPS, CH) 3.1 The principles of Sprints & Scrums 10 3.1.1 Planning and setting up a Sprint 10 3.1.2 Executing the Sprint 10 3.2 Documents 11 3.2.1 Sprint document 11 3.2.2 Bi-weekly Sprint Reports 11 4.1 Deliverable Editor 12 4.2 Deliverable Versions 12 4.3 Deliverables List 12 4.4 Deliverables Review Procedures 12 4.5 Deliverable Template 13 4.6 Software Deliverables 13 4.7 Deliverable References 13 6.1 Consortium Meetings 16 6.2 Emailing lists 16 6.3 Skype 17 6.4 Contact List 17 6.5 Meetings 17 6.5.1 Planning and Preparation 17 6.5.2 Minutes 17 6.6 Project Language 18 7.1 SharePoint 19 7.2 Version Control 19 7.3 Documentation 19
View Source
AIT AUSTRIAN INSTITUTE OF TECHNOLOGY. GMBH (AIT, Project Coordinator, AT) Partner 2: UNIVERSITY OF GENEVA (UniGe, CH) Partner 3: UNIVERSITY OF CYPRUS (UCY, CY) Partner 4 ORBIS MEDISCH EN ZORGCONCERN (ORBIS, NL) Partner 5 FRAUNHOFER IGD (Fh-IGD, DE) Partner 6 Noldus Information Technology BV (Noldus, NL) Partner 7 CITARD SERVICES LTD (Citard, CY) Partner 8 ZOOBE MESSAGE ENTERTAINMENT GMBH (Zoobe, DE) Partner 9 MAISON DE RETRAITE DU PETIT-SACONNEX (MRPS, CH) 3.1 Introduction to this chapter 5 3.2 Hardware requirements 5 3.2.1 Server 5 3.2.2 Workstation 5
View Source
AIT AUSTRIAN INSTITUTE OF TECHNOLOGY. GMBH (AIT, Project Coordinator, AT) Partner 2: UNIVERSITY OF GENEVA (UniGe, CH) Partner 3: UNIVERSITY OF CYPRUS (UCY, CY) Partner 4 ORBIS MEDISCH EN ZORGCONCERN (ORBIS, NL) Partner 5 FRAUNHOFER IGD (Fh-IGD, DE) Partner 6 Noldus Information Technology BV (Noldus, NL) Partner 7 CITARD SERVICES LTD (Citard, CY) Partner 8 ZOOBE MESSAGE ENTERTAINMENT GMBH (Zoobe, DE) Partner 9 MAISON DE RETRAITE DU PETIT-SACONNEX (MRPS, CH) 1.1 Role of the deliverable 2 1.2 Relationship to other Miraculous-Life deliverables 2 1.3 Structure of this document 3
View Source
AIT AUSTRIAN INSTITUTE OF TECHNOLOGY. GMBH (AIT, Project Coordinator, AT) Partner 2: UNIVERSITY OF GENEVA (UniGe, CH)
View Source

Related to AIT AUSTRIAN INSTITUTE OF TECHNOLOGY

  • Manufacturing Technology Transfer Except as provided in Section 4.3(f)(iii)(1) and Section 6.10, with respect to any Collaboration Product (or LGC Reserved Product, if applicable) for which LGC (or its Affiliate) performed CMC Development or CMC Manufacturing, if (a) Cue does not elect for LGC to perform CMC Step 2, CMC Step 3, or CMC Step 4 (or with respect to LGC Reserved Products, upon completion of CMC Step 1), or (b) upon failure of the Parties to reach agreement with respect to a Clinical Supply Agreement or a Commercial Supply Agreement or (c) [***] under this Agreement and does not cure such breach within [***] days (provided, that if such breach is not reasonably capable of cure within such [***] day period, then such cure period shall be automatically extended for an additional [***] day period as long as LGC continues to use diligent efforts to cure such breach in accordance with a reasonable cure plan and if such breach is not reasonably capable of cure within such combined [***] day period, then Cue shall reasonably consider consenting to any extension of such cure period as long as LGC continues to use diligent efforts to cure such breach in accordance with a reasonable cure plan), as applicable, then, in each case upon the written request of Cue, LGC shall use Commercially Reasonable Efforts to make a technology transfer to an Approved CMO the Manufacturing processes (including materials and such other information) but solely as is necessary to enable the Manufacture of such Collaboration Product (including the Collaboration Compound therein) (or LGC Reserved Product, including the LGC Reserved Compound therein, if applicable) by such Approved CMO to comparable biochemical structure, quality and purity as that Manufactured by LGC or its Affiliate or CMO, provided that neither Cue, LGC or any Third Party shall perform such a technology transfer to any CMO [***] without LGC’s consent, not to be unreasonably withheld, conditioned or delayed if LGC has approved the CMO to manufacture Collaboration Products (or LGC Reserved Products, if applicable). LGC shall conduct such technology transfer as soon as reasonably practicable after receiving such written notice, using good faith efforts to support supply needed to achieve timelines in the Cue Territory Development Plan (or Cue’s development plan for LGC Reserved Products, if applicable) or Cue Territory Commercialization Plan, as applicable. LGC shall conduct the first technology transfer for each Collaboration Product (or LGC Reserved Products, if applicable) [***] (provided that [***]) for a period of up to [***] months from the date Cue or its designee has provided notice it is ready to receive the technology transfer, provided, that such [***] month period [***]. After the expiration of the initial such [***] month period for a Collaboration Product (or LGC Reserved Products, if applicable), if required to complete the technology transfer to enable the Manufacture of such Collaboration Product (including the Collaboration Compound therein) (or LGC Reserved Product, including the LGC Reserved Compound therein, if applicable) by such Approved CMO to comparable biochemical structure, quality and purity as that Manufactured by LGC, LGC shall continue to provide support to Cue for up to an additional [***] period for up to [***] hours at the FTE Rate and thereafter at [***]. Thereafter, LGC will also provide [***] for such Collaboration Product (or LGC Reserved Products, if applicable). Neither Cue nor its Affiliates or Cue Collaborators shall reverse engineer any materials provided hereunder by LGC. Notwithstanding anything in this Agreement to the contrary, LGC’s CMC information may only be shared with an Approved CMO.

  • Diagnostic Services Procedures ordered by a recognized Provider because of specific symptoms to diagnose a specific condition or disease. Some examples include, but are not limited to:

  • Technology Discoveries, innovations, Know-How and inventions, whether patentable or not, including computer software, recognized under U.S. law as intellectual creations to which rights of ownership accrue, including, but not limited to, patents, trade secrets, maskworks and copyrights developed under this Agreement.

  • New Technology When new or updated technology is introduced into a workplace, it will be the responsibility of the employer to provide appropriate and, if necessary, ongoing training to the employees directly affected. Such training will include any health and safety implications or information that will enable employees to operate the equipment without discomfort and will help maintain their general well-being.

  • Technology License 4.1 Unless any event described in Article 2.2 or 2.3 of this Agreement occurs, all of the technology required to be licensed for any of Party B’s business shall be provided by Party A on an exclusive basis. Party A will try its best to license Party B to use the technology owned by Party A, or re-license Party B to use the technology as approved by the owner. 4.2 The Parties shall negotiate with each other to enter into specific technology license contracts to expressly specify the detail matters such as the technology to be licensed, the method to license the technology, license fees and payment.